NCT02940483View on ClinicalTrials.gov

Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Ependymoma

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

November 28, 2018

Study Completion Date

November 28, 2018

Conditions
Brain Tumor Recurrent
Interventions
DRUG

5-Azacytidine

5-Azacytidine 10 mg into the fourth ventricle of the brain via the Ommaya reservoir 1 day a week for 12 weeks.

Trial Locations (1)

77030

UTHealth & Children's Memorial Hermann Hospital, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT02940483 - Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Ependymoma | Biotech Hunter | Biotech Hunter